HCPCS Level IIdrugActive
J7190
Factor viii
BETOS: O1E
Effective: 1999-01-01
Referenced in 5 policies
Description
Factor viii (antihemophilic factor, human) per i.u.
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Hemofil M
Manufacturer
Takeda Pharmaceuticals America, Inc.
HCPCS Dosage
1 IU
Billing Units
1.0000
7
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.